Home › Lung Cancer › Michigan › Waterford
Lung Cancer clinical trials in Waterford, MI
9 studies for Lung Cancer are looking for participants at sites in and around Waterford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RecruitingPhase 3
- Michigan Healthcare Professionals Pontiac, Pontiac · 7 mi away
- Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac · 7 mi away
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Hematology Oncology Consultants-Clarkston, Clarkston · 3 mi away
- Michigan Healthcare Professionals Pontiac, Pontiac · 7 mi away
- Newland Medical Associates-Pontiac, Pontiac · 7 mi away
- and 1 more
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecruitingPhase 3
- Hematology Oncology Consultants-Clarkston, Clarkston · 3 mi away
- Michigan Healthcare Professionals Pontiac, Pontiac · 7 mi away
- Newland Medical Associates-Pontiac, Pontiac · 7 mi away
- and 1 more
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Hematology Oncology Consultants-Clarkston, Clarkston · 3 mi away
- Trinity Health IHA Medical Group - Primary Care - Clarkston, Clarkston · 3 mi away
- Michigan Healthcare Professionals Pontiac, Pontiac · 7 mi away
- and 2 more
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac · 7 mi away
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecruitingPhase 3
- McLaren Cancer Institute-Clarkston, Clarkston · 3 mi away
- Michigan Healthcare Professionals Clarkston, Clarkston · 3 mi away
- Michigan Healthcare Professionals Pontiac, Pontiac · 7 mi away
- and 1 more
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac · 7 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac · 7 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac · 7 mi away
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Arlington, VA41 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Other studies in Waterford
- Breast Cancer8 studies
- Non-Small Cell Lung Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Prostate Cancer7 studies
- Colorectal Cancer5 studies
- Head and Neck Squamous Cell Carcinoma4 studies
- Hypopharyngeal Cancer4 studies
- Laryngeal Cancer4 studies
- Oral Cancer4 studies
- Multiple Myeloma3 studies
- Cancer (all types)3 studies
- Colon Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.